Page last updated: 2024-08-22

coformycin and Neoplasms

coformycin has been researched along with Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamson, RH; Chassin, MM; Harrap, KR; Jackman, AL; Johns, DG; Paine, RM; Smyth, JF1
Bruno, S; Macdonald, JS; Marsoni, S; Poster, D1
Harrap, KR; Paine, RM; Smyth, JF1
Calabresi, P; Crabtree, GW; Cummings, FJ; Parks, RE; Spremulli, EN; Wiemann, MC1
Berger, NA; Lazarus, HM1
Marsoni, S; O'Dwyer, PJ; Spiers, AS1
Hubbell, HR; Lee, C; Pequignot, EC; Suhadolnik, RJ; Willis, DH1

Reviews

1 review(s) available for coformycin and Neoplasms

ArticleYear
Chemotherapy of malignant disease: an update.
    Comprehensive therapy, 1988, Volume: 14, Issue:5

    Topics: Amsacrine; Antineoplastic Agents; Cisplatin; Coformycin; Etoposide; Female; Humans; Ifosfamide; Male; Mitoxantrone; Neoplasms; Pentostatin; Pregnancy

1988

Other Studies

6 other study(ies) available for coformycin and Neoplasms

ArticleYear
The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Cancer chemotherapy and pharmacology, 1980, Volume: 5, Issue:2

    Topics: Adenosine Deaminase Inhibitors; Adult; Aged; Animals; Coformycin; Dogs; Female; Humans; Kinetics; Leukemia, Lymphoid; Lymphocytes; Male; Middle Aged; Nausea; Neoplasms; Nucleoside Deaminases; Pentostatin; Ribonucleosides; Uric Acid

1980
Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1982, Volume: 80

    Topics: Adenosine Deaminase Inhibitors; Aminoacridines; Amsacrine; Anthracenes; Antineoplastic Agents; Coformycin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia; Mitoxantrone; Neoplasms; Nucleoside Deaminases; Pentostatin; Ribonucleosides

1982
Biochemical consequences of treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Advances in experimental medicine and biology, 1979, Volume: 122B

    Topics: Adolescent; Adult; Animals; Coformycin; Drug Evaluation; Erythrocytes; Humans; Lectins; Lymphocyte Activation; Lymphocytes; Male; Mice; Middle Aged; Neoplasms; Organ Size; Pentostatin; Ribonucleosides; Ribonucleotides; Spleen

1979
Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin.
    Clinical pharmacology and therapeutics, 1988, Volume: 44, Issue:5

    Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Adult; Aged; Antineoplastic Agents; Coformycin; Female; Humans; Immunity; Immunosuppressive Agents; Male; Middle Aged; Neoplasms; Nucleoside Deaminases; Pentostatin; Ribonucleosides

1988
Association of severe and fatal infections and treatment with pentostatin.
    Cancer treatment reports, 1986, Volume: 70, Issue:9

    Topics: Adolescent; Adult; Aged; Bacterial Infections; Child; Coformycin; Drug Evaluation; Female; Herpes Zoster; Humans; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Neoplasms; Pentostatin; Ribonucleosides

1986
Differential antiproliferative actions of 2',5' oligo A trimer core and its cordycepin analogue on human tumor cells.
    International journal of cancer, 1985, Sep-15, Volume: 36, Issue:3

    Topics: Adenine Nucleotides; Adenosine; Cell Division; Cell Line; Coformycin; Culture Techniques; Dose-Response Relationship, Drug; Drug Resistance; Humans; Neoplasms; Oligodeoxyribonucleotides; Oligonucleotides; Oligoribonucleotides; Pentostatin

1985